GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chia Tai Enterprises International Ltd (HKSE:03839) » Definitions » Debt-to-Equity

Chia Tai Enterprises International (HKSE:03839) Debt-to-Equity : 0.29 (As of Sep. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Chia Tai Enterprises International Debt-to-Equity?

Chia Tai Enterprises International's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was HK$413 Mil. Chia Tai Enterprises International's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was HK$123 Mil. Chia Tai Enterprises International's Total Stockholders Equity for the quarter that ended in Sep. 2024 was HK$1,835 Mil. Chia Tai Enterprises International's debt to equity for the quarter that ended in Sep. 2024 was 0.29.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Chia Tai Enterprises International's Debt-to-Equity or its related term are showing as below:

HKSE:03839' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.03   Med: 0.12   Max: 0.35
Current: 0.3

During the past 11 years, the highest Debt-to-Equity Ratio of Chia Tai Enterprises International was 0.35. The lowest was 0.03. And the median was 0.12.

HKSE:03839's Debt-to-Equity is ranked worse than
52.21% of 816 companies
in the Drug Manufacturers industry
Industry Median: 0.28 vs HKSE:03839: 0.30

Chia Tai Enterprises International Debt-to-Equity Historical Data

The historical data trend for Chia Tai Enterprises International's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chia Tai Enterprises International Debt-to-Equity Chart

Chia Tai Enterprises International Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.09 0.17 0.21 0.34 0.30

Chia Tai Enterprises International Quarterly Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.34 N/A 0.35 0.29 0.30

Competitive Comparison of Chia Tai Enterprises International's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Chia Tai Enterprises International's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chia Tai Enterprises International's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Chia Tai Enterprises International's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Chia Tai Enterprises International's Debt-to-Equity falls into.


;
;

Chia Tai Enterprises International Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Chia Tai Enterprises International's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Chia Tai Enterprises International's Debt to Equity Ratio for the quarter that ended in Sep. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Chia Tai Enterprises International  (HKSE:03839) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Chia Tai Enterprises International Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Chia Tai Enterprises International's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Chia Tai Enterprises International Business Description

Traded in Other Exchanges
N/A
Address
16 Harcourt Road, 21st Floor, Far East Finance Centre, Hong Kong, HKG
Chia Tai Enterprises International Ltd is engaged in the manufacture and sale of chlortetracycline (CTC) and animal health products. The company's operating segment includes Biochemical operations and Industrial operations. It generates maximum revenue from the Biochemical operations segment, which is engaged in the manufacture and sale of chlortetracycline and animal health products. The Industrial segment is into trading of machinery and the manufacture and sale of automotive parts through the group's joint venture and associate. Its geographical segments are Mainland China which generates key revenue, Asia Pacific (excluding mainland China), Americas, Europe, and Others.

Chia Tai Enterprises International Headlines

No Headlines